BRCA2: A genetic risk factor for breast cancer

Cancer Letters

Volumn 175, Issue 1, 2002, Pages 1-8

  Schwab, Manfred ^a   Claas, Andreas ^a   Savelyeva, Larissa ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

9p; Ataxia telangiectasia; BRCA2; Breast cancer; Chromosome aberration; Cowden syndrome; CRAZY 9; DNA repair; Double stranded break; Familial cancer; Genetic instability; Growth control; Hereditary cancer syndrome; Li Fraumeni syndrome; Modifier gene; Muir Torre syndrome; Mutation; Peutz Jegher syndrome; RAD51; Transcription

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN;

ATAXIA TELANGIECTASIA; BREAST CANCER; CANCER GENETICS; CANCER GROWTH; CANCER SUSCEPTIBILITY; COWDEN SYNDROME; DISEASE COURSE; DNA RECOMBINATION; DNA REPAIR; GENE FUNCTION; GENE MAPPING; GENE MUTATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; HIGH RISK POPULATION; HUMAN; MUIR TORRE SYNDROME; PEUTZ JEGHERS SYNDROME; PREDICTION; PRIORITY JOURNAL; SHORT SURVEY; TRANSCRIPTION REGULATION;

ATAXIA; ATAXIA TELANGIECTASIA;

EID: 0037049881     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(01)00752-2     Document Type: Review

References (68)

1. Breast cancer: Magnitude of the problem and descriptive epidemiology
2. Causes of breast cancer and high risk groups, incidence and demographics
3. The increasing incidence of breast cancer since 1982: Relevance of early detection
4. Breast cancer incidence among atomic bomb survivors, Hiroshima and Nagasaki
5. Incidence of female breast cancer among atomic bomb survivors, 1950-1985
6. Breast cancer
7. Risk factors for breast cancer in women with proliferative breast disease
8. Combined effect of childbearing, menstrual events, and body size on age-specific breast cancer risk
9. Projected changes in breast cancer incidence due to the trend toward delayed childbearing
10. Menopause and breast cancer risk
11. A. strong, candidate for the breast and ovarian cancer susceptibility gene BRCA1
12. Identification of the breast cancer susceptibility gene BRCA2
13. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium
14. Genes implicated in hereditary breast cancer syndromes
15. The molecular basis and clinical aspects of Peutz-Jeghers syndrome
16. Genetic and hormonal risk factors in breast cancer
17. Candidate gene analysis and preliminary genomic search results for mapping of non-BRCA1/2 breast cancer genes
18. Polymorphisms in PTEN in breast cancer families
19. Microsatellite instability and expression of hMlH-2 in sebaceaous gland carcinomas as markers for Muir-Torre syndrome
20. Li-Fraumeni syndrome - A molecular and clinical review
21. Screening for germ line TP53 mutations in breast cancer patients
22. Genetic linkage analysis in familial breast and ovarian cancer: Results from 214 families
23. Genetic aspects of atacia-telangiectasia
24. Incidence of cancer in 161 families affected by ataxia-telangiectasia
25. Risk of breast cancer and other cancers in heterozygotes for ataxia-telangiectasia
26. Breast cancer risk in ataxia telangiectasia (AT) heterozygotes: Haplotype study in French AT families
27. Heterozygous ATM mutations do not contribute to early onset of breast cancer
28. Identification of germline missense mutations and rare allelic variants in the ATM gene in early-onset breast cancer
29. The role of ataxia-telangiectasia heterozygotes in familial breast cancer
30. A.T.M. mutations, in cancer families
31. Cancer-susceptibility genes. Gatekeepers and caretakers
32. Lessons learned from BRCA1 and BRCA2
33. Consistent loss of the wild type allele in breast cancers from a family linked to the BRCA2 gene on chromosome 13q12-13
34. Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13
35. Murine Brca2: Sequence, map position, and expression pattern
36. Tumorigenesis and a DNA repair defect in mice with a truncating Brca2 mutation
37. Thymic lymphomas in mice with a truncating mutation in Brca2
38. Embryonic lethality and radiation hypersensitivity mediated by Rad 51 in mice lacking Brca2
39. Gross chromosomal rearrangements and genetic exchange between nonhomologous chromosomes following BRCA2 inactivation
40. The breast cancer susceptibility gene, BRCA2: At the crossroads between DNA replication and recombination?
41. The BRC repeats in BRCA2 are critical for RAD51 binding and resistance to methyl methanesulfonate treatment
42. RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2
43. Mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53
44. Synergistic actions of Rad51 and Rad52 in recombination and DNA repair
45. Genetic analysis of gamma-ray mutagenesis in yeast III. Double-mutant strains
46. Role of the human RAD51 protein in homologous recombination and double-stranded-break repair
47. A. surfeit, of RAD51-like genes?
48. Chromosomal stability and the DNA double-stranded break connection
49. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells Mol
50. Induction of phosphorylation on BRCA1 during cell cycle and after DNA damage
51. Dynamic changes of BRCA1 subnuclear location and phosphorylation state are initiated by DNA damage
52. Dose-rate effect on induction and repair rate of radiation-induced DNA double-strand breaks in a normal and an ataxia telangiectasia human fibroblast cell line
53. Linkage of ATM to cell cycle regulation by the Chk2 protein kinase
54. A.T.M. phosphorylates, p95/nbs1 in an S-phase checkpoint pathway
55. ATM phosphorylation of Nijmegen breakage syndrome protein is required in a DNA damage response
56. Functional link between ataxia-telangiectasia and Nijmegen breakage syndrome gene products
57. ATM-dependent phosphorylation of nibrin in response to radiation exposure
58. Insights into the functions of BRCA1 and BRCA2
59. An interstitial tandem duplication of 9p-23-24 coexists with a mutation in the BRCA2 gene in the germ line of three brothers with breast cancer
60. Constitutional genomic instability with inversions, duplications, and amplifications in 9p23-24 in BRCA2 mutation carriers
61. Amplification of oncogenes revisited: From expression profiling to clinical application
62. The BRCA2 activation domain associates with and is phosphorylated by a cellular protein kinase
63. BRCA2 associates with acetyltransferase activity when bound to P/CAF
64. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A
65. A. human, BRCA2 complex containing a structural DNA binding component influences cell cycle progression
66. BRCA1 mutations in young women with breast cancer
67. Frequency and carrier risk associated with common BRCA and BRCA2 mutations in Ashkenazi Jewish breast cancer patients
68. Breast cancer genetics: What we know and what we need